Melinda Gates Bets $46.6M on Magnify Ventures Fund II

On July 2, Magnify Ventures Fund II landed at $46.6 million, giving the care economy another validation point from Melinda French Gates’ Pivotal Ventures.

The early-stage firm raised the fund from LPs including Pivotal Ventures, according to TechCrunch. The signal is sharper than the headline suggests. Magnify isn’t pitching care as charity-adjacent venture. It’s treating household labor, family finance, aging, health, and caregiving as markets where AI and infrastructure software can create venture-scale companies.

That thesis still has to prove itself. But the new fund shows that care-focused venture capital has moved beyond the “interesting niche” stage.

July 2: Magnify Ventures Fund II puts care startups on notice

Magnify Ventures, founded in 2021 by Joanna Drake and Julie Wroblewski, invests in companies targeting the care economy. TechCrunch lists examples including assistive robotics, family cybersecurity, and AI for home use.

Fund II will back companies building:

• AI tools: Products for households and home management.
• Health and home systems: Infrastructure around care delivery and family needs.
• Fintech infrastructure: Tools for families managing money, expenses, and protection.

That focus matters because the firm is not simply investing in consumer apps with softer branding. It is aiming at the operating layer of family life. The strongest version of the Magnify Ventures Fund II thesis is that care is full of unpaid, fragmented, and poorly digitized work, and that software can reduce friction without pretending human caregiving disappears.

Femtech Insider reported that the fund is backed by returning investor Pivotal Ventures, alongside new investors Jordan Park and Unum, with financing from California’s Infrastructure and Economic Development Bank, or IBank.

“We’re at a real inflection point in some of the world’s largest, most underleveraged markets: care, wealth, aging, and the broader health, consumer and financial systems that shape family life,” said co-founder and managing partner Julie Wroblewski, according to Femtech Insider.

That is the core bet. Not “care” as sentiment. Care as infrastructure.

From $52M in 2022 to $46.6M in 2026: momentum, not victory

Magnify last raised a $52 million Fund I in 2022, with Pivotal Ventures anchoring that fund, according to TechCrunch. Fund II is smaller at $46.6 million, but the repeat backing matters more than the difference in headline size.

XOOMAR analysis: A sub-$50 million specialist fund will not, by itself, reprice women’s health, childcare, elder care, or family finance. It can, however, shape the earliest deal flow before broader investors decide a category is obvious. That is where specialist funds earn their right to exist.

The broader category data gives Magnify some cover. Femtech Insider cited research from The Holding Co. in partnership with Pivotal Ventures showing that venture interest in the care economy has accelerated by 45% over the past four years, with more than $26 billion invested in over 700 companies since 2015. The same report described a $648 billion market opportunity spanning pregnancy through end-of-life caregiving, and the healthcare, financial, and consumer systems around families.

Those numbers support Magnify’s argument that the category is investable. They don’t guarantee returns. The difference between a large addressable market and a good venture portfolio is execution, distribution, and timing.

Pivotal Ventures’ repeat backing changes the signal

Pivotal Ventures is not a passive name on the cap table in this story. TechCrunch notes that Pivotal generally acts as both a GP and LP, backing companies building in the care economy.

Its portfolio includes caregiving startups Papa and Seen Health. Magnify was also an investor in Papa, according to TechCrunch. That overlap suggests shared conviction, not a one-off institutional allocation.

Pivotal’s role gives Magnify credibility with three groups that matter:

• Founders: Especially those building in markets generalist VCs may misread as too operational, too regulated, or too low-margin.
• Co-investors: Funds that may need a category specialist to validate early signals.
• Later-stage capital: Investors that will eventually decide whether these companies deserve larger rounds.

XOOMAR analysis: Pivotal’s backing is a validation point, but it’s not the finish line. The hard test is whether Magnify can produce venture outcomes while staying focused on populations and workflows that made the thesis compelling in the first place. Care startups can drift toward higher-income, easier-to-serve customers if their business models demand it. That would weaken the social logic of the category, even if some companies still grow.

Fund I’s portfolio shows where Magnify thinks care infrastructure breaks

Magnify’s prior investments give a clearer view of its thesis than the phrase “care economy” alone.

TechCrunch named Kinside, a childcare startup, and Till Financial, a children’s expense management startup, among companies backed by Fund I. Pivotal Ventures was also an investor in Till Financial.

Those examples sit at different points in family life. Kinside points to childcare access and coordination. Till Financial points to family money management and financial habits. Papa points to caregiving and support services.

This is why Magnify Ventures Fund II is better understood as a family infrastructure fund than a narrow women’s health fund. Women’s health is part of the thesis, and Wroblewski specifically referenced “women’s health” in the Femtech Insider report. But the fund’s stated remit also runs through aging, longevity, fintech, household AI, and home systems.

That breadth is useful, but it creates risk. A fund that invests across health, wealth, family care, home systems, and AI needs a tight view of where it has sourcing edge. Otherwise, “care economy” becomes too broad to discipline investment decisions.

For readers tracking how specialist capital is moving across venture, XOOMAR has also covered Deep Tech Bet Pulls Ashton Kutcher From Sound Ventures and the narrower science-focused thesis in Common Cold Fund Wagers $500 Million to Kill Sniffles.

Founders, LPs, employers, and families won’t judge Fund II the same way

Magnify’s stakeholders will use different scorecards.

XOOMAR analysis: This mismatch is the central tension in care investing. Families don’t care whether a startup fits a venture narrative. They care whether it helps them find care, manage health, protect money, or reduce household chaos. LPs, by contrast, need evidence that those pain points can become durable companies.

That is where AI could help, but only if it reduces actual labor. Femtech Insider said Fund II will target applied AI that reduces the “invisible labor” of running a household, as well as agentic tools across health and home systems. In this context, agentic tools means software that can take multi-step actions with less direct human prompting. The practical question is simple: can those tools make care coordination cheaper, faster, or more reliable?

The next test: care conviction has to become durable outcomes

Magnify Ventures Fund II makes care infrastructure harder for early-stage investors to ignore. It also raises the bar for the category.

The evidence that would strengthen Magnify’s thesis is specific: portfolio companies showing measurable savings, better access, improved care coordination, lower administrative burden, or financial products families actually keep using. Later-stage rounds from credible investors would help. So would strategic interest from buyers in health, financial services, home care, or family-benefits channels.

The evidence that would weaken it is just as clear: high customer acquisition costs, low retention, weak margins, privacy failures, or products that appeal mostly to affluent households while missing broader care needs.

Magnify has capital, category focus, and a repeat backer in Pivotal Ventures. Now it needs proof. If Fund II turns care economy conviction into durable company outcomes, the category will look less like a diversity side pocket and more like a serious early-stage investing thesis.

The Bottom Line

• The $46.6 million fund signals growing investor conviction in care economy startups.
• Backing from Pivotal Ventures gives Magnify’s thesis added credibility with institutional capital.
• The fund targets infrastructure, AI, health, and fintech tools for underserved household and caregiving needs.